Theranovir
Develops therapies targeting cancer, obesity-related diseases and viral infections for patients and healthcare markets
Highlights
- New on EvolcAdded 2026-11-13
About Theranovir
Theranovir is a French health technology company conducting research and development on therapies for cancer, obesity-related metabolic diseases and infectious diseases. Its approach targets signaling pathways regulated by the NRP-1/OBR protein complex.
The company’s operational team and scientific advisory board include drug-development, clinical, oncology and pharmaceutical industry expertise. It was founded in 2018 and is headquartered in Évry-Courcouronnes, France.
Product: Research and development of therapies targeting cancer, obesity-related metabolic diseases and viral infections through the NRP-1/OBR pathway.
Jobs at Theranovir
Leadership
- Zakia BELAID-SANDAL · Chief Executive Officer, FounderSource: company website
- Adyl CHAHET · Chief Financial OfficerSource: company website
More biotech & pharma companies
Theravectys
Lentiviral vector vaccine candidates for cancers and chronic infectious diseases, developed with Institut PasteurNew on EvolcTissium
Biomorphic programmable polymers for tissue reconstruction in surgery, developed for medtech and surgical useTranscure Bioservices
Preclinical CRO running humanized and conventional mouse model studies for drug developers in oncology, inflammation and infectious diseaseucbcares.fr
Patient and healthcare professional support service for UCB treatments, offering information and phone assistance in FranceNew on EvolcUPSA
French pharmaceutical laboratory making self-medication drugs, dietary supplements and medical devices for patients and pharmacistsUrosphere
Preclinical urogenital disease models and in vivo/in vitro testing services for drug developers in Toulouse
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.